68001-541-36 |
68001-541 |
HUMAN PRESCRIPTION DRUG |
Bortezomib |
Bortezomib |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20220731 |
N/A |
ANDA |
ANDA209622 |
BluePoint Laboratories |
BORTEZOMIB |
3.5 mg/3.5mL |
1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE |
72205-183-01 |
72205-183 |
HUMAN PRESCRIPTION DRUG |
Bortezomib |
Bortezomib |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20220727 |
N/A |
ANDA |
ANDA209622 |
Novadoz Pharmaceuticals LLC |
BORTEZOMIB |
3.5 mg/3.5mL |
1 VIAL, SINGLE-USE in 1 CARTON (72205-183-01) / 3.5 mL in 1 VIAL, SINGLE-USE |
83090-008-01 |
83090-008 |
HUMAN PRESCRIPTION DRUG |
Bortezomib |
Bortezomib |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS; SUBCUTANEOUS |
20230715 |
N/A |
ANDA |
ANDA209622 |
Sintetica US LLC |
BORTEZOMIB |
3.5 mg/3.5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83090-008-01) / 3.5 mL in 1 VIAL, SINGLE-DOSE |